Who we are
TIB MOLBIOL® – Fast. Precise. Flexible.
We develop reliable real-time PCR based tests at high speed and ensure that laboratories and patients get the answers they need – without fuss or frills, just in true Berlin style.
At TIB MOLBIOL, molecular diagnostics isn’t just what we do – it’s what we’ve been refining for over 35 years. We develop, manufacture, and supply real-time PCR kits, primer and probe sets, and key components used in medical diagnostics, research, and industrial manufacturing worldwide.
Founded in Berlin in 1990 and part of the Roche family since 2021, we combine the agility of a biotech pioneer with the reach of a global healthcare leader. Inside Roche, we’re known as the “speedboat” – developing high-quality molecular diagnostic assays for platforms like cobas® 5800/6800/8800, LightCycler® Pro, and Digital LightCycler®.
When new challenges emerge, our team acts fast. With a proven track record of rapid response, we’ve developed and delivered molecular diagnostic solutions for global outbreaks within weeks - helping labs and hospitals stay ahead when timing is critical.
Our approach is simple: science first, no fuss, no overcomplication. Just fast, precise, and flexible molecular diagnostics that labs can rely on every day.
TIB MOLBIOL and Roche:
A long-standing partnership
Our collaboration with Roche began long before TIB MOLBIOL joined the Roche Group in December 2021.
For more than 20 years, we have worked together to develop real-time PCR assays in response to emerging infectious diseases and public health threats, including SARS, anthrax, H5N1, MERS, H1N1, Ebola, Zika, and SARS-CoV-2.
A significant milestone came in January 2020, when we jointly introduced a research-use-only PCR test for SARS-CoV-2, just days after the virus's genetic sequence was published. This achievement demonstrated how our combined expertise in PCR assay development and molecular testing technologies enables a rapid response to emerging pathogens.
Today, as part of Roche Diagnostics, we combine TIB MOLBIOL's expertise in flexible PCR assay development with Roche's established diagnostic platforms and global reach. Together, our molecular testing portfolio includes more than 70 CE-IVD assays and over 300 research-use-only (RUO) assays for LightCycler® and cobas® PCR systems. This broad range of molecular diagnostic and research solutions gives laboratories access to testing options for both routine applications and emerging challenges.
Our DNA
Our DNA is rooted in developing reliable real-time PCR assays at speed, so laboratories and patients get the answers they need when they matter most - without fuss or frippery, just the Berlin way.
We work closely with customers and local scientific experts to develop molecular diagnostic solutions that meet the needs of laboratories.
Our Response to Disease Outbreaks
When new infectious disease outbreaks emerge, we act fast to develop and deliver reliable real-time PCR assays that address urgent testing needs. From SARS-CoV-2 to Ebola, our experience in rapid assay development and close scientific collaboration enables laboratories to respond to evolving public health threats.
How It All
Began
Founded in Berlin in 1990, TIB MOLBIOL began with the custom synthesis of oligonucleotides, producing short DNA and RNA sequences tailored to specific research needs.
Initially serving scientific research, environmental analysis, and industrial quality control, our expertise gradually expanded into molecular diagnostics, including PCR assays for detecting pathogens and genetic variants.
Today, our broader portfolio still follows the same principle: practical science built around what laboratories need.
